TRANZYME INC·4

Oct 21, 1:41 PM ET

ROUSSEAU FRANCK 4

4 · TRANZYME INC · Filed Oct 21, 2011

Insider Transaction Report

Form 4
Period: 2011-10-18
ROUSSEAU FRANCK
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2011-10-18+175,000175,000 total
    Exercise: $2.97Exp: 2021-10-18Common Stock (175,000 underlying)
Footnotes (2)
  • [F1]Option to purchase Common Stock granted by the Issuer pursuant to the Issuer's 2011 Stock Option and Incentive Plan, qualified under Rule 16b-3(d).
  • [F2]25% of the shares will vest and become exercisable on October 18, 2012, with the remainder vesting and becoming exercisable in equal quarterly installments for the following 12 quarters thereafter.

Documents

1 file
  • 4
    a4.xmlPrimary

    4